School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.
Sonova AG, Staefa, Switzerland.
Int J Audiol. 2024 Oct;63(10):747-752. doi: 10.1080/14992027.2023.2278018. Epub 2023 Dec 7.
The effectiveness of audiological monitoring for detecting early hearing changes in patients receiving ototoxic medication could be limited by the lack of adequate audiological ototoxicity monitoring (OtoM) guidelines. This study aimed to evaluate existing OtoM guidelines using the AGREE II tool for guideline evaluation.
Guideline Review.
Three audiological OtoM guidelines.
An online search identified three audiological OtoM guidelines published by the American Speech-Language and Hearing Association (ASHA), the American Academy of Audiology (AAA) and the Health Professionals Council of South Africa (HPCSA). Evaluation using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool found the HPCSA audiological OtoM guideline scored higher than the ASHA and AAA guidelines in five of the six tool domains. All guidelines received average domain ratings of less than 50% with each reviewer recommending all three guidelines for use following modification.
The findings of this study could partly explain the poor uptake of audiological OtoM practices internationally, further investigation is needed to identify the specific factors limiting the implementation of audiological OtoM in clinical practice.
由于缺乏充分的听力学药物性聋监测(OtoM)指南,听力学监测在检测接受耳毒性药物治疗的患者早期听力变化方面的效果可能会受到限制。本研究旨在使用 AGREE II 工具评估现有的 OtoM 指南。
指南回顾。
三项听力学 OtoM 指南。
通过在线搜索,确定了美国言语-语言听力协会(ASHA)、美国听力学学会(AAA)和南非卫生专业人员理事会(HPCSA)发布的三项听力学 OtoM 指南。使用评估指南研究与评估(AGREE) II 工具进行评估发现,HPCSA 的听力学 OtoM 指南在六个工具领域中的五个领域的得分均高于 ASHA 和 AAA 指南。所有指南的各领域评分均低于 50%,每位审核员均建议在修改后使用这三项指南。
本研究的结果部分解释了国际上听力学 OtoM 实践采纳率低的原因,需要进一步调查以确定限制听力学 OtoM 在临床实践中实施的具体因素。